Login

Nikolaj Sørensen, CEO, Orexo 00:00:00

Share On Facebook Share On Twitter

Orexo

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Unlocking Wealth Potential: The Strategic Advantage of Roth Conversions by Raquel Hinman | Raquel Hinman - Founder & Principal of Hinman Financial Planning, Inc.
00:10:00
Renewable Energy Transition and Expertise in Solar and Wind Power | Hicham Chad, Director ,Taqa Morocco SA.
00:10:00
Guiding the City of London Investment Trust to Sustained Growth
00:10:00
Dennis Prager on American Exceptionalism and the Clash of Ideologies
00:10:00
BNN Market Movers April 8 - Athabasca Oil | Robert Broen, CEO, Athabasca Oil CorpATH:TOR
00:10:00
The REIT is listed on the Singapore stock exchange and focuses in Industrial & logistic properties in Singapore and Australia|CEO,AIMS APAC REIT
00:10:00
Navigating Corporate Reputational Risks, Core Business Health, and Trade Concerns| Paul Pittman, CEO, Farmland Partners Inc.
00:10:00
Revolutionizing Climate Solutions|Ryan Gembala,Managing Partner & Founder,Pathbreaker Ventures
00:00:00
Destiny Pharma's nasal spray project already delivering - Neil Clark, CEO, Destiny Pharma
00:10:00
From Football Dreams to Financial Triumphs: The Journey of UBS's CEO | Sergio Ermotti , CEO , UBS.
00:10:00
George Peristeris: Pioneering Pathways in Terna Energy |George Peristeris, Chairman, Terna Energy SA.
00:00:00
CEL-SCI Corp letter to shareholders details positive results from Phase 3 study of Multikine - Geert R. Kersten Director and Chief Executive Officer, CEL-SCI Corp

© 2017 - Neuhu+